Johnson & Johnson
NYSEJohnson & Johnson enters the second week of May having shed a month's worth of bearish positioning, even as the stock itself is down 7% from a month ago — a divergence that sits at the heart of this week's setup. The most consequential move has been the steady unwind in short interest. At its early-April peak, shorts held nearly 1% of the free float. By May 5, that figure had fallen…
Snapshot as of 6 May 2026
A new long-form analysis for JNJ this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumJohnson & Johnson enters the second week of May having shed a month's worth of bearish positioning, even as the stock itself is down 7% from a month ago — a divergence that sits at the heart of this week's setup. The…
Johnson & Johnson heads into the final day of April with the story squarely about one thing: a decisive unwinding of short positions that began during the tariff-shock selloff and accelerated through Q1 earnings…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JNJ — free to start on ORTEX.
Sign up for free →Open JNJ on ORTEX